Clinical Trials Browser

Borderline Resectable Pancreatic Adenocarcinoma

Colorectal Neoplasms

Triple Negative Breast Neoplasms

Pancreatic Neoplasms

Carcinoma, Hepatocellular

Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Biliary Tract Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms, Colorectal Neoplasms

Colorectal Adenocarcinoma Metastatic to the Liver

Colorectal Neoplasms

Colonic Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Neoplasm Metastasis

Colorectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Esophagogastric Cancer

Neuroblastoma, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms

Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Colonic Neoplasms, Rectal Neoplasms

Colorectal Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Adenocarcinoma, Neoplasm Metastasis, Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Clinical Trials

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer

TNBC

QUILT-3.088: NANT Pancreatic Cancer Vaccine

Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE

Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery

FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

Neoadjuvant Therapy for Localized Rectal Adenocarcinoma

IMMUNOX

Novel Oncology Therapies in Combination With Adjuvant Chemo in High-risk MSS-CRC

Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver

A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.

A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer

Hepatic Arterial Infusion With FOLFOX Alone or in Combination With IV Chemotherapy in Colon Cancer With Liver Metastasis

MEGAN

PRIMIER

Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer

Phase II Study of Zaltrap and Chemotherapy for Advanced Resectable Colorectal Cancer

Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer

Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor

Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia

Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer

Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal Cancer

S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum

FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer

Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer

Colorectal Cancer RECHALLENGE